Amylin concentrations and glucose control
- 1 May 1992
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 339 (8802), 1179-1180
- https://doi.org/10.1016/0140-6736(92)90785-2
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Amylin injection causes elevated plasma lactate and glucose in the ratFEBS Letters, 1991
- In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscleDiabetes, 1991
- Amylin activates glycogen phosphorylase in the isolated soleus muscle of the ratFEBS Letters, 1991
- Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissuesDiabetologia, 1991
- Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in Type 2 (non-insulin-dependent) diabetic patientsDiabetologia, 1991
- Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humansDiabetologia, 1991
- Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humansDiabetes, 1990
- Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitusBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1989
- Summary of Current Diabetes-related Data from the National Center for Health StatisticsDiabetes Care, 1979